Treatment of portosystemic encephalopathy with the benzodiazepine-receptor antagonist flumazenil (a randomized, double-blind, placebo-controlled, multicenter study)

Category Primary study
JournalGastroenterology
Year 1994
This article has no abstract
Epistemonikos ID: a6dca5d188b46c1c29f99137ed8c9afce877bb2d
First added on: Mar 20, 2017